A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.

Lin, C C; Hsu, C H; Chen, J; Tsai, T C; Cheng, A L; Pu, Y S

Lin, C C; Hsu, C H; Chen, J; Tsai, T C; Cheng, A L; Pu, Y S.

Affiliation

Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

Anticancer Res ; 21(2B): 1385-90, 2001.

Article in En | MEDLINE | ID: mdl-11396219

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Prostatic Neoplasms/drug therapy; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Doxorubicin/adverse effects; Doxorubicin/therapeutic use; Fluorouracil/adverse effects; Fluorouracil/therapeutic use; Follow-Up Studies; Humans; Leucovorin/adverse effects; Leucovorin/therapeutic use; Male; Middle Aged; Pilot Projects; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Prostatic Neoplasms/mortality; Survival Rate; Tamoxifen/adverse effects; Tamoxifen/therapeutic use; Treatment Failure; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2001 Document type: Article Affiliation country: Taiwan Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links